These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 37768184)

  • 21. Poor agreement between diagnostic tests for latent tuberculosis infection among HIV-infected persons in Hong Kong.
    Leung CC; Chan K; Yam WC; Lee MP; Chan CK; Wong KH; Ho PL; Mak I; Tam CM
    Respirology; 2016 Oct; 21(7):1322-9. PubMed ID: 27121551
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Relating Tuberculosis (TB) Contact Characteristics to QuantiFERON-TB-Gold and Tuberculin Skin Test Results in the Toronto Pediatric TB Clinic.
    Rose W; Read SE; Bitnun A; Rea E; Stephens D; Pongsamart W; Kitai I
    J Pediatric Infect Dis Soc; 2015 Jun; 4(2):96-103. PubMed ID: 26407408
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Screening for latent tuberculosis in Norwegian health care workers: high frequency of discordant tuberculin skin test positive and interferon-gamma release assay negative results.
    Gran G; Aßmus J; Dyrhol-Riise AM
    BMC Public Health; 2013 Apr; 13():353. PubMed ID: 23590619
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Risk factors associated with positive QuantiFERON-TB Gold In-Tube and tuberculin skin tests results in Zambia and South Africa.
    Shanaube K; Hargreaves J; Fielding K; Schaap A; Lawrence KA; Hensen B; Sismanidis C; Menezes A; Beyers N; Ayles H; Godfrey-Faussett P
    PLoS One; 2011 Apr; 6(4):e18206. PubMed ID: 21483746
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The Clinical Usefulness of Tuberculin Skin Test versus Interferon-Gamma Release Assays for Diagnosis of Latent Tuberculosis in HIV Patients: A Meta-Analysis.
    Ayubi E; Doosti-Irani A; Sanjari Moghaddam A; Sani M; Nazarzadeh M; Mostafavi E
    PLoS One; 2016; 11(9):e0161983. PubMed ID: 27622293
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Two interferon gamma release assays for predicting active tuberculosis: the UK PREDICT TB prognostic test study.
    Abubakar I; Lalvani A; Southern J; Sitch A; Jackson C; Onyimadu O; Lipman M; Deeks JJ; Griffiths C; Bothamley G; Kon OM; Hayward A; Lord J; Drobniewski F
    Health Technol Assess; 2018 Oct; 22(56):1-96. PubMed ID: 30334521
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Evaluation of the QuantiFERON?-TB Gold In-Tube assay and tuberculin skin test for the diagnosis of Mycobacterium tuberculosis infection in northeastern Thailand.
    Reechaipichitkul W; Pimrin W; Bourpoern J; Prompinij S; Faksri K
    Asian Pac J Allergy Immunol; 2015 Sep; 33(3):236-44. PubMed ID: 26342121
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The association of smoking with IGRA and TST results in HIV-1-infected subjects.
    Aichelburg MC; Mandorfer M; Tittes J; Breitenecker F; Reiberger T; Rieger A; Kohrgruber N
    Int J Tuberc Lung Dis; 2014 Jun; 18(6):709-16. PubMed ID: 24903943
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Prospective comparison of the tuberculin skin test and 2 whole-blood interferon-gamma release assays in persons with suspected tuberculosis.
    Mazurek GH; Weis SE; Moonan PK; Daley CL; Bernardo J; Lardizabal AA; Reves RR; Toney SR; Daniels LJ; LoBue PA
    Clin Infect Dis; 2007 Oct; 45(7):837-45. PubMed ID: 17806047
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Assessment of the QuantiFERON-TB Gold In-Tube test for the detection of Mycobacterium tuberculosis infection in United States Navy recruits.
    Lempp JM; Zajdowicz MJ; Hankinson AL; Toney SR; Keep LW; Mancuso JD; Mazurek GH
    PLoS One; 2017; 12(5):e0177752. PubMed ID: 28545136
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effects of Pregnancy and Isoniazid Preventive Therapy on Mycobacterium tuberculosis Interferon Gamma Response Assays in Women With HIV.
    Weinberg A; Aaron L; Montepiedra G; Sterling TR; Browning R; Mmbaga B; Vhembo T; Naik S; Kabugho E; Masheto G; Pahwa S; Mathad JS; LaCourse SM; McCarthy K; Bradford S; Theron G; Costello D; Zimmer B; Pierre MF; Gausi K; Denti P; Haas DW; Gupta A;
    Clin Infect Dis; 2021 Nov; 73(9):e3555-e3562. PubMed ID: 32720695
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Concordance between the tuberculin skin test and interferon gamma release assay (IGRA) for diagnosing latent tuberculosis infection in patients with systemic lupus erythematosus and patient characteristics associated with an indeterminate IGRA.
    Cho H; Kim YW; Suh CH; Jung JY; Um YJ; Jung JH; Kim HA
    Lupus; 2016 Oct; 25(12):1341-8. PubMed ID: 26985011
    [TBL] [Abstract][Full Text] [Related]  

  • 33. School based screening for tuberculosis infection in Norway: comparison of positive tuberculin skin test with interferon-gamma release assay.
    Winje BA; Oftung F; Korsvold GE; Mannsåker T; Ly IN; Harstad I; Dyrhol-Riise AM; Heldal E
    BMC Infect Dis; 2008 Oct; 8():140. PubMed ID: 18928541
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Relation between BCG vaccine scar and an interferon-gamma release assay in immigrant children with "positive" tuberculin skin test (≥10 mm).
    Gudjónsdóttir MJ; Kötz K; Nielsen RS; Wilmar P; Olausson S; Wallmyr D; Trollfors B
    BMC Infect Dis; 2016 Oct; 16(1):540. PubMed ID: 27716176
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A toolbox for tuberculosis (TB) diagnosis: an Indian multicentric study (2006-2008). Evaluation of QuantiFERON-TB gold in tube for TB diagnosis.
    Lagrange PH; Thangaraj SK; Dayal R; Deshpande A; Ganguly NK; Girardi E; Joshi B; Katoch K; Katoch VM; Kumar M; Lakshmi V; Leportier M; Longuet C; Malladi SV; Mukerjee D; Nair D; Raja A; Raman B; Rodrigues C; Sharma P; Singh A; Singh S; Sodha A; Kabeer BS; Vernet G; Goletti D
    PLoS One; 2013; 8(9):e73579. PubMed ID: 24039990
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Interferon Gamma Release Assay versus Tuberculin Skin Testing among Healthcare Workers of Highly Diverse Origin in a Moderate Tuberculosis Burden Country.
    Al Hajoj S; Varghese B; Datijan A; Shoukri M; Alzahrani A; Alkhenizan A; AlSaif A; Althawadi S; Fernandez G; Alrajhi A
    PLoS One; 2016; 11(5):e0154803. PubMed ID: 27148876
    [TBL] [Abstract][Full Text] [Related]  

  • 37. An observational study identifying highly tuberculosis-exposed, HIV-1-positive but persistently TB, tuberculin and IGRA negative persons with M. tuberculosis specific antibodies in Cape Town, South Africa.
    Kroon EE; Kinnear CJ; Orlova M; Fischinger S; Shin S; Boolay S; Walzl G; Jacobs A; Wilkinson RJ; Alter G; Schurr E; Hoal EG; Möller M
    EBioMedicine; 2020 Nov; 61():103053. PubMed ID: 33038764
    [TBL] [Abstract][Full Text] [Related]  

  • 38. QuantiFERON-TB Gold In-Tube Test for Tuberculosis Prevention in HIV-Infected Patients.
    Khawcharoenporn T; Phetsuksiri B; Rudeeaneksin J; Srisungngam S; Apisarnthanarak A
    Jpn J Infect Dis; 2017 Sep; 70(5):502-506. PubMed ID: 28367883
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Interferon-γ release assays and tuberculin skin testing for diagnosis of latent tuberculosis infection in healthcare workers in the United States.
    Dorman SE; Belknap R; Graviss EA; Reves R; Schluger N; Weinfurter P; Wang Y; Cronin W; Hirsch-Moverman Y; Teeter LD; Parker M; Garrett DO; Daley CL;
    Am J Respir Crit Care Med; 2014 Jan; 189(1):77-87. PubMed ID: 24299555
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Screening of latent tuberculosis infection among health care workers working in Hajj pilgrimage area in Saudi Arabia, using interferon gamma release assay and tuberculin skin test.
    Bukhary ZA; Amer SM; Emara MM; Abdalla ME; Ali SA
    Ann Saudi Med; 2018; 38(2):90-96. PubMed ID: 29620541
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.